Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

A proprietary blend of quail egg for the attenuation of nasal provocation with a standardized allergenic challenge: a randomized, double-blind, placebo-controlled study.

Benichou AC, Armanet M, Bussière A, Chevreau N, Cardot JM, Tétard J.

Food Sci Nutr. 2014 Nov;2(6):655-63. doi: 10.1002/fsn3.147. Epub 2014 Jul 20.

2.

Omacetaxine mepesuccinate in patients with advanced chronic myeloid leukemia with resistance or intolerance to tyrosine kinase inhibitors.

Khoury HJ, Cortes J, Baccarani M, Wetzler M, Masszi T, Digumarti R, Craig A, Benichou AC, Akard L.

Leuk Lymphoma. 2015 Jan;56(1):120-7. doi: 10.3109/10428194.2014.889826. Epub 2014 Apr 28.

PMID:
24650054
3.

Subcutaneous omacetaxine mepesuccinate in patients with chronic-phase chronic myeloid leukemia previously treated with 2 or more tyrosine kinase inhibitors including imatinib.

Cortes JE, Nicolini FE, Wetzler M, Lipton JH, Akard L, Craig A, Nanda N, Benichou AC, Leonoudakis J, Khoury HJ, Hochhaus A, Baccarani M, Kantarjian HM.

Clin Lymphoma Myeloma Leuk. 2013 Oct;13(5):584-91. doi: 10.1016/j.clml.2013.03.020. Epub 2013 Jun 17.

4.

Omacetaxine mepesuccinate for patients with accelerated phase chronic myeloid leukemia with resistance or intolerance to two or more tyrosine kinase inhibitors.

Nicolini FE, Khoury HJ, Akard L, Rea D, Kantarjian H, Baccarani M, Leonoudakis J, Craig A, Benichou AC, Cortes J.

Haematologica. 2013 Jul;98(7):e78-9. doi: 10.3324/haematol.2012.083006. Epub 2013 Jun 10. No abstract available.

5.

Phase 2 study of subcutaneous omacetaxine mepesuccinate for chronic-phase chronic myeloid leukemia patients resistant to or intolerant of tyrosine kinase inhibitors.

Cortes J, Digumarti R, Parikh PM, Wetzler M, Lipton JH, Hochhaus A, Craig AR, Benichou AC, Nicolini FE, Kantarjian HM; Omacetaxine 203 Study Group.

Am J Hematol. 2013 May;88(5):350-4. doi: 10.1002/ajh.23408. Epub 2013 Mar 7.

6.

Pharmacokinetic study of omacetaxine mepesuccinate administered subcutaneously to patients with advanced solid and hematologic tumors.

Nemunaitis J, Mita A, Stephenson J, Mita MM, Sarantopoulos J, Padmanabhan-Iyer S, Nanda N, Gleich L, Benichou AC, Craig A.

Cancer Chemother Pharmacol. 2013 Jan;71(1):35-41. doi: 10.1007/s00280-012-1963-2. Epub 2012 Oct 4.

7.

Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation.

Cortes J, Lipton JH, Rea D, Digumarti R, Chuah C, Nanda N, Benichou AC, Craig AR, Michallet M, Nicolini FE, Kantarjian H; Omacetaxine 202 Study Group.

Blood. 2012 Sep 27;120(13):2573-80. Epub 2012 Aug 15.

8.

Identification of novel plant peroxisomal targeting signals by a combination of machine learning methods and in vivo subcellular targeting analyses.

Lingner T, Kataya AR, Antonicelli GE, Benichou A, Nilssen K, Chen XY, Siemsen T, Morgenstern B, Meinicke P, Reumann S.

Plant Cell. 2011 Apr;23(4):1556-72. doi: 10.1105/tpc.111.084095. Epub 2011 Apr 12.

9.

Variability in free mycophenolic acid exposure in adult liver transplant recipients during the early posttransplantation period.

Benichou AS, Blanchet B, Conti F, Hornecker M, Bernard D, Taieb F, Scatton O, Abbas H, Harcouet L, Dauphin A, Calmus Y, Tod M.

J Clin Pharmacol. 2010 Oct;50(10):1202-10. doi: 10.1177/0091270009358084. Epub 2010 Feb 9.

PMID:
20145258
11.

Development and validation of an HPLC-UV-visible method for sunitinib quantification in human plasma.

Blanchet B, Saboureau C, Benichou AS, Billemont B, Taieb F, Ropert S, Dauphin A, Goldwasser F, Tod M.

Clin Chim Acta. 2009 Jun 27;404(2):134-9. doi: 10.1016/j.cca.2009.03.042. Epub 2009 Mar 31.

PMID:
19341717
12.

Validation of an HPLC-UV method for sorafenib determination in human plasma and application to cancer patients in routine clinical practice.

Blanchet B, Billemont B, Cramard J, Benichou AS, Chhun S, Harcouet L, Ropert S, Dauphin A, Goldwasser F, Tod M.

J Pharm Biomed Anal. 2009 May 1;49(4):1109-14. doi: 10.1016/j.jpba.2009.02.008. Epub 2009 Feb 20.

PMID:
19278805
14.

Double emulsions stabilized with hybrids of natural polymers for entrapment and slow release of active matters.

Benichou A, Aserin A, Garti N.

Adv Colloid Interface Sci. 2004 May 20;108-109:29-41.

PMID:
15072926
15.

Elimination of free-living amoebae in fresh water with pulsed electric fields.

Vernhes MC, Benichou A, Pernin P, Cabanes PA, Teissié J.

Water Res. 2002 Aug;36(14):3429-38.

PMID:
12230188
16.

Recent biotechnological developments of electropulsation. A prospective review.

Teissié J, Eynard N, Vernhes MC, Bénichou A, Ganeva V, Galutzov B, Cabanes PA.

Bioelectrochemistry. 2002 Jan;55(1-2):107-12. Review.

PMID:
11786352
17.

[You have said, "Detractors"].

Bénichou A.

Ann Fr Anesth Reanim. 2000 Aug;19(7):564-6. French. No abstract available.

PMID:
10976377
18.

Mycobacterium bovis BCG genes involved in the biosynthesis of cyclopropyl keto- and hydroxy-mycolic acids.

Dubnau E, Lanéelle MA, Soares S, Bénichou A, Vaz T, Promé D, Promé JC, Daffé M, Quémard A.

Mol Microbiol. 1997 Jan;23(2):313-22.

19.

[Midazolam versus placebo before spinal anesthesia].

Fletcher D, Samii K, Bénichou A, Fillette D, Bertin A, Germond M, Laverdisse D, Mascaro JM, Normand E, Piroelle Y, et al.

Cah Anesthesiol. 1995;43(5):497-9. French.

PMID:
8564679
20.

[Sedation for diagnostic and therapeutic procedures in urology].

Bénichou A, Bruelle P.

Cah Anesthesiol. 1995;43(2):119-22. French. No abstract available.

PMID:
7671071
21.

[Biological reference values in the human fetus. 106 cord blood sampling in utero].

Berrebi A, Bénichou AC, Sarramon MF, Bessières MH, Rolland M, Kobuch WE, Demur C, Solera ML, Sie P, Amouroux J, et al.

J Gynecol Obstet Biol Reprod (Paris). 1992;21(4):355-9. French.

PMID:
1624719
22.

[Discount on anesthetic safety].

Benichou A, Du Grés B.

Ann Fr Anesth Reanim. 1991;10(5):423-4. French. No abstract available.

PMID:
1755550
23.

[Phenoperidine and operative common bile duct pressure (author's transl)].

Olivero de Rubiana JP, Ghesquière F, Garen C, Mourot N, Benichou A, Richer R, Langlois P.

Anesth Analg (Paris). 1980;37(7-8):409-12. French.

PMID:
6107061
24.

[Enteral feeding with reinjection in the terminal gut (author's transl)].

Ghesquière F, Olivero de Rubiana JP, Garen C, Benichou A, Mourot N, Richer R.

Anesth Analg (Paris). 1979 May-Jun;36(5-6):251-4. French.

PMID:
115341
25.

[Surgery of hepatic hydatic cyst. Per-operative complications. Possibility of anaphylactic etiology (author's transl)].

Ghesquière F, Mourot N, Olivero de Rubiana JP, Benichou A, Garen C, Chigot JP.

Anesth Analg (Paris). 1979;36(11-12):561-3. French.

PMID:
95469

Supplemental Content

Loading ...
Support Center